Moneycontrol
Get App
SENSEX NIFTY
you are here:

Kilitch Drugs (India) Ltd.

BSE: 524500 | NSE: KILITCH |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE729D01010 | SECTOR: Pharmaceuticals

BSE Live

Apr 09, 16:00
110.00 -4.85 (-4.22%)
Volume
AVERAGE VOLUME
5-Day
1,966
10-Day
1,681
30-Day
2,383
2,508
  • Prev. Close

    114.85

  • Open Price

    120.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Apr 09, 15:59
110.95 -3.65 (-3.19%)
Volume
AVERAGE VOLUME
5-Day
38,103
10-Day
27,122
30-Day
20,501
53,772
  • Prev. Close

    114.60

  • Open Price

    117.10

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    110.95 (111)

Company History - Kilitch Drugs (India)
 M/s Kilitch Drugs (India) ltd was incorporated on 12th May, 1992 with
 the Registrar of Companies, Maharashtra at Bombay as a public limited
 company and obtained certificate for commencement of business dated
 26-05-92. The company went Public in February 1994 for setting up a
 pharmaceutical formulation plant to manufacture pharmaceutical
 products in the form of tablets, capsules, liquid orals, ointments,
 creams and injectables. The company could not commence its
 manufacturing activities as planned in the Public Issue on account of
 delay in completion of building. Till date, the company has not
 commenced any manufacturing activities. The land and building is now
 completed and in order to have the benefit of its capacity, the
 company is planning this rights issue for expanding its injectable
 capacity from 30,000 ltrs. to 75,000 Itrs.
 Due to delay in implementation of project, the company could not come
 out with its own production till date and therefore the company is
 presently trading in pharmaceutical formulations like tablets,
 capsules, liquid orals, ointments, creams and injectables. The
 trading turnover of the company for the year 1994-95 was Rs.550.50
 Lacs.
 
 
 2008
 
 -Board recommends final dividend of 10%.
 
 2009
 
 -The Company got a GOLD AWARD for Quality Excellence.
 
 
 2010
 
 -Listing of Equity Shares at NSE.
 
 2011
 
 2015
 -Kilitch Drugs entered joint venture with local firm in Ethopia